WO2018214297A1 - Portable device and method for non-invasive blood glucose detection - Google Patents

Portable device and method for non-invasive blood glucose detection Download PDF

Info

Publication number
WO2018214297A1
WO2018214297A1 PCT/CN2017/098189 CN2017098189W WO2018214297A1 WO 2018214297 A1 WO2018214297 A1 WO 2018214297A1 CN 2017098189 W CN2017098189 W CN 2017098189W WO 2018214297 A1 WO2018214297 A1 WO 2018214297A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood glucose
pulse wave
signal
invasive blood
wave signal
Prior art date
Application number
PCT/CN2017/098189
Other languages
French (fr)
Chinese (zh)
Inventor
张贯京
葛新科
高伟明
张红治
梁昊原
陈琦
周亮
Original Assignee
深圳市前海安测信息技术有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳市前海安测信息技术有限公司 filed Critical 深圳市前海安测信息技术有限公司
Publication of WO2018214297A1 publication Critical patent/WO2018214297A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes

Definitions

  • the present invention relates to the field of non-invasive blood glucose detecting technology, and in particular to a portable non-invasive blood glucose detecting device and method.
  • diabetes has become one of the major diseases that endanger human health in modern society. Hyperglycemia is too high or too low to affect not only the patient's metabolism, but also some complications, such as cardiovascular disease and neuropathy, which pose a great threat to the health of patients. According to the World Health Organization report, there will be 300 million people with diabetes worldwide by 2035, and a large proportion of people with diabetes in China will also be present. In recent years, patients with diabetes have not only existed in some elderly people, but also in some young people. Diabetes is a chronic disease that is difficult to achieve with a single treatment, so people with diabetes need to know exactly what their blood sugar levels are.
  • an invasive blood glucose detecting method is adopted, that is, the patient's blood is directly taken, and the blood sugar level of the patient is detected according to an electrochemical method.
  • This method of detection causes certain physical pain to the patient, and repeated blood draws are likely to cause infection.
  • electrochemical reaction test papers are expensive, and are also a large economic burden for diabetic patients.
  • Non-invasive blood glucose testing can eliminate the pain of patient detection, can be frequently detected, improve the quality of life of patients
  • the main object of the present invention is to provide a portable non-invasive blood glucose detecting device and method, aiming at solving the technical problem that the existing non-invasive blood glucose detecting method has low accuracy and accuracy for blood glucose detecting. Problem solution
  • the present invention provides a portable non-invasive blood glucose detecting device, comprising a signal collector and a non-invasive blood glucose detecting device, wherein a signal processing circuit is connected between the signal collector and the non-invasive blood glucose detecting device, wherein:
  • the signal collector includes an upper detecting plate, a lower detecting plate, an infrared light source, and a photoelectric sensor;
  • the infrared light source is embedded in a lower surface of the front end of the upper detecting plate, and is configured to emit near-infrared light to be irradiated on a part to be tested;
  • the photoelectric sensor is embedded on the front surface of the front end of the lower detecting plate, and is configured to acquire a pulse wave signal from a portion to be tested of the human body under the illumination of the near-infrared light and send a signal processing circuit to perform signal pre-processing;
  • the non-invasive blood glucose detecting device includes a microprocessor and a memory, wherein the memory stores a non-invasive blood glucose detecting system, wherein the non-invasive blood glucose detecting system is composed of a plurality of instructions and stored in a memory, wherein the plurality of instructions are micro
  • the processor loads and performs the following steps:
  • the initial detection value is displayed on the display screen as the human blood glucose concentration value.
  • the signal collector further includes a support frame, the upper end of the support frame is provided with a sliding slot, one end of the upper detecting board is disposed in the sliding slot, and the lower detecting board is fixed at a lower end of the supporting frame And set parallel to the axis of the upper detection plate.
  • the upper surface of the lower detecting plate is provided with a hinge mechanism, and the upper end of the hinge mechanism is provided with a return spring and is connected to the upper detecting plate through a return spring, and the lower end of the hinge mechanism is provided with a support rod and passes through The support rod is fixed to the upper surface of the lower detection plate.
  • the front surface of the front end of the lower detecting plate is further provided with a detecting portion for placing a portion to be tested of the human body, and the photoelectric sensor is disposed in the detecting portion.
  • the infrared light source comprises at least a plurality of the near-infrared light emitting tube 800 n m-1500nm band, a human body part to be measured for transmitting at least a near infrared light comprises 800nm -l 500nm band signal.
  • the present invention also provides a non-invasive blood glucose detecting method, which is applied to a portable non-invasive blood glucose detecting device, and the non-invasive blood glucose detecting method includes the steps of:
  • the signal processing circuit controls the infrared light source to emit near-infrared light to be irradiated on the part to be tested;
  • the photoelectric sensor acquires a pulse wave signal from a portion to be tested of the human body and transmits the pulse wave signal to the signal processing circuit;
  • the signal processing circuit performs signal pre-processing on the pulse wave signal
  • the non-invasive blood glucose detecting device acquires a pulse wave signal from the signal processing circuit, and extracts a feature value of the acquired pulse wave signal;
  • the non-invasive blood glucose detecting device uses the predicted neural network to detect the characteristic value of the pulse wave signal to obtain an initial detected value of the blood glucose concentration;
  • the non-invasive blood glucose detecting device uses a classification neural network to detect a characteristic value of the pulse wave signal to obtain a detection interval of the blood glucose concentration;
  • the non-invasive blood glucose detecting device determines whether the initial detected value belongs to the detection interval
  • the non-invasive blood glucose detecting device displays the initial detection value on the display screen as the human blood glucose concentration value.
  • the non-invasive blood glucose detecting method comprises the steps of: further comprising: if the initial detection value is not in the detection interval, the non-invasive blood glucose detecting device discards the initial detection value and detects the next pulse wave signal until the initial detection value Until the detection interval.
  • the step of the signal processing circuit performing signal pre-processing on the pulse wave signal comprises the following steps: filtering the pulse wave signal to remove noise and DC components in the pulse wave signal, leaving a required AC component Amplifying and analog-to-digital converting the pulse wave signal to obtain a digital signal of the pulse wave signal, and transmitting the digital signal to the non-invasive blood glucose detecting device.
  • the infrared light source comprises at least a plurality of near-infrared light-emitting tubes in a wavelength range of 800 n m to 1500 nm, and is configured to emit near-infrared light including a band of 800 n m to 1500 nm to a portion to be tested of the human body.
  • the non-invasive blood glucose detecting method comprises the steps of: further comprising the steps of: the non-invasive blood glucose detecting device detects each time a plurality of pulse wave signals are collected in the preset frequency band to obtain a plurality of blood glucose detecting results; The non-invasive blood glucose detecting device calculates the average value of the same blood glucose detecting result after removing the maximum value and the minimum value from the plurality of blood sugar detecting results, and uses the average value as the final human blood sugar concentration value.
  • Advantageous effects of the invention Beneficial effect
  • the portable non-invasive blood glucose detecting device and method of the present invention uses a pulse wave signal obtained by predicting a neural network to obtain a detection interval to which a blood glucose concentration belongs, and determines a pulse wave signal obtained by the classification neural network. Obtaining whether the initial detection value of the blood glucose concentration belongs to the detection interval, and when the initial detection value is within the detection interval, the initial detection value is a blood glucose concentration value, and by determining the interval to which the initial detection value belongs, the human body can be effectively reduced.
  • the interference of other components in the blood on blood glucose concentration improves the accuracy and accuracy of blood glucose concentration detection.
  • FIG. 1 is a schematic structural view of a preferred embodiment of a portable non-invasive blood glucose detecting device of the present invention
  • FIG. 2 is a schematic structural view of a non-invasive blood glucose detecting device in the portable non-invasive blood glucose detecting device of the present invention
  • FIG. 3 is a flow chart of a preferred embodiment of the non-invasive blood glucose detecting method of the present invention.
  • 5 is a detailed flowchart of the feature value of the extracted pulse wave signal in step S33 of FIG. 3.
  • FIG. 1 is a schematic structural view of a preferred embodiment of a portable non-invasive blood glucose detecting device of the present invention.
  • the portable non-invasive blood glucose detecting device comprises a signal collector 1 and a non-invasive blood glucose detecting device 2, wherein: the signal collecting device 1 is configured to collect and output a pulse wave signal.
  • the non-invasive blood glucose detecting device 2 is connected to the signal collector 1 for detecting the pulse wave signal (PP G signal) output from the signal collector 1 to obtain the blood glucose concentration of the test subject.
  • PP G signal pulse wave signal
  • the signal collector 1 includes a support frame 10, an upper detection plate 11, a lower detection plate 12, an infrared light source 13, and a photosensor 14.
  • the upper end of the support frame 10 is provided with a sliding slot 100, and the upper inspection
  • One end of the measuring plate 11 is movably connected to the sliding slot 100, that is, the upper detecting plate 11 can be moved up and down in the sliding slot 100, so that the distance between the upper detecting plate 11 and the lower detecting plate 12 can be adjusted, and the human body of different sizes can be placed.
  • the blood glucose test is performed at the measurement site, which improves the flexibility and applicability of the device.
  • the lower detecting plate 12 is fixed to the lower end of the support frame 10 and disposed in parallel with the axis of the upper detecting plate 11.
  • the upper surface of the lower detecting plate 12 is provided with a hinge mechanism 16, and both ends of the hinge mechanism 16 are provided with a return spring 17, and are connected to the upper detecting plate 11 by a return spring 17.
  • the lower end of the hinge mechanism 16 is provided with a support rod 18 which is fixed to the upper surface of the lower detecting plate 12 by a support rod 18.
  • the upper detecting plate 11 is located at a position directly above the hinge mechanism 16 and is provided with a screw hole 110, and the screw hole 110 is provided with an internal thread.
  • the upper end of the hinge mechanism 16 is fixed with a screw 111.
  • the outer surface of the screw 111 is provided with an external thread, and the screw 111 passes through the screw hole 110 and the external thread of the screw 111 matches the inner thread of the screw hole 110. Since the hinge mechanism 16 is connected to the upper detecting plate 11 through the return spring 17, the user can manually rotate the screw 111 to move the upper detecting plate 11 up and down to bring the return spring 17 up and down and compress, so that the upper detecting plate 11 can be moved along the sliding groove 100.
  • the distance between the upper detecting plate 11 and the lower detecting plate 12 can be adjusted.
  • the infrared light source 13 is embedded in the lower surface of the front end of the upper detecting plate 11, and the photoelectric sensor 14 is embedded on the front surface of the front end of the lower detecting plate 12, because the upper detecting plate 11 and the lower detecting plate 12 are arranged in parallel. Therefore, the infrared light source 13 and the photosensor 14 are disposed coaxially.
  • the photosensor 14 is disposed in the detecting portion 15, and the detecting portion 15 is provided with a front surface of the front end of the lower detecting plate 12 for providing a blood sugar concentration detecting place, which can be used for placing the human body.
  • a portion to be tested such as a human finger capillary tip, an ear lobe, or a wrist, such as a human capillary-dense body tissue
  • the infrared light source 13 is a near-infrared light emitting tube for transmitting an optical signal including at least near-infrared light to the detecting portion 15 as
  • the infrared light source 13 may include a plurality of near-infrared light-emitting tubes in the 800 n m-1500 nm band, the peak wavelength deviation of the near-infrared light-emitting tube is ⁇ 10 nm, and the radiation power is greater than 3 mW; the photosensor 14 is configured to receive the passing detection portion 15 The subsequent optical signal is converted into
  • the wavelength band received by the photosensor 14 can be set such that the optical signal received by the photosensor 14 is in the near-infrared band, specifically, the photoelectric sensor. 14
  • the peak wavelength deviation received is ⁇ 10 nm
  • the photocurrent is greater than 10 uA
  • the peak wavelength deviation received by photosensor 14 is less than ⁇ 10. Nm.
  • the infrared light source 13 may include optical signals of other wavelength bands, but needs to meet the optical signal sent by the infrared light source 13 to Less includes near-infrared light.
  • a signal processing circuit 3 can be connected between the signal collector 1 and the non-invasive blood glucose detecting device 2.
  • the signal processing circuit 3 is connected to the infrared light source 13 of the signal collector 1 through a control line and is connected to the photosensor 14 of the signal collector 1 and the non-invasive blood sugar detecting device 2 through a signal line.
  • the signal processing circuit 3 controls the infrared light source 13 to emit and emits near-infrared light to be irradiated on the body to be tested, and the photoelectric sensor 14 is used to detect the portion from the human body. Acquire the pulse wave signal and perform signal pre-processing on the pulse wave signal.
  • the signal output from the photosensor 14 is converted, preamplified, filtered, and the like.
  • the filter can be used to filter the pulse wave signal, and the noise and DC components in the pulse wave signal can be removed to leave a desired AC component;
  • the pulse wave signal is amplified and Analog-to-digital conversion, as an example, a signal amplifier can be used to amplify the pulse wave signal, using a 12-bit analog-to-digital converter
  • the sampling frequency can be, for example, 1 ⁇ to obtain a digital signal of the pulse wave signal, and the digital signal is sent to the non-invasive blood sugar detecting device 2 for subsequent processing.
  • the pulse wave signal may be a photoplethysmographic pulse signal or a bioimpedance signal or a pressure sensing signal.
  • the pulse wave signal collected by the photosensor 14 is a photoplethysmographic pulse signal (PPG signal).
  • the signal processing circuit 3 can also supply power to the signal collector 1 (e.g., the infrared source 13 and the photosensor 14).
  • the upper surface of the upper detecting board 11 is further provided with a power switch 19, which is connected between the infrared light source 13 and the signal processing circuit 3 through a power line, and is used to activate the infrared light source 13 to emit near-infrared light. , or turn off the infrared light source 13 to stop emitting near-infrared light.
  • a power switch 19 which is connected between the infrared light source 13 and the signal processing circuit 3 through a power line, and is used to activate the infrared light source 13 to emit near-infrared light. , or turn off the infrared light source 13 to stop emitting near-infrared light.
  • the PPG signal is acquired to select the earlobe or fingertip of the human body as a portion for extracting the PPG signal, and the earlobe or fingertip is placed on the detecting portion 15 of the signal collector 1.
  • the blood of the fingertips and the earlobe is relatively abundant.
  • the photoelectric signal can be detected periodically by the photoelectric sensor.
  • the external influence factors need to be minimized or changed.
  • the earlobe or fingertip is the most suitable site for extracting PPG signals.
  • the photoelectric volume pulse wave is obtained by transmitting the human skin tissue through the near-infrared spectrum or by reflecting the human skin tissue.
  • FIG. 2 is a schematic structural view of the non-invasive blood glucose detecting device 2.
  • the non-invasive blood glucose detecting device 2 includes a microprocessor 21, a memory 22, and a display screen 23.
  • the memory 21 is stored
  • a non-invasive blood glucose detecting system 20 is stored, which is composed of a plurality of modules composed of various instructions and stored in the memory 22.
  • the non-invasive non-invasive blood glucose detecting system 20 includes, but is not limited to, a signal acquisition module 201, an eigenvalue extraction module 202, an initial detection module 203, an interval detection module 204, and a blood glucose value output module 205.
  • a module referred to in the present invention refers to a series of computer program instructions executable by the microprocessor 20 and capable of performing a fixed function, which are stored in the memory 21.
  • the microprocessor 21 may be a central processing unit (CPU), a microcontroller (MCU), a data processing chip, or an information processing unit having a data processing function.
  • the memory 22 can be a read only memory unit ROM, an electrically erasable memory unit EEPROM, a flash memory unit FLASH or a solid state hard disk.
  • the display screen 23 is a small-sized LCD or LED display unit that is mounted on the outer surface of the casing of the non-invasive blood glucose detecting device 2, since the measured blood sugar concentration value of the human body is displayed. This embodiment will specifically illustrate the functions of the various modules in the non-invasive blood glucose detecting system 20 in conjunction with Figs. 3, 4 and 5.
  • the present invention also discloses a non-invasive blood glucose detecting method. As shown in Figs. 1 and 2, the non-invasive blood glucose detecting method includes the following steps:
  • Step S31 when the user turns on the power of the signal collector 1 , the signal processing circuit 3 controls the infrared light source 13 to emit near-infrared light to be irradiated on the part to be tested, and the photosensor 14 is obtained from the body to be tested.
  • the pulse wave signal is sent to the signal processing circuit 3 for pre-processing the pulse wave signal.
  • the infrared light source 13 may emit a plurality of near-infrared light 800 n m-1500nm band tube
  • the photosensor 14 acquires the pulse wave signals from parts of the body to be measured
  • the signal processing circuit 3 acquires the pulse wave from the photosensor 14 Signal
  • signal processing such as signal conversion, preamplification and filtering of the pulse wave signal.
  • Step S32 the signal acquisition module 201 acquires a pulse wave signal from the signal processing circuit 3.
  • the so-called pulse wave signal carries the blood glucose concentration information of the sample to be tested.
  • the so-called pulse wave signal is preferably a photoplethysmographic pulse signal.
  • the glucose formula contains multiple 0-H, CH chemical bonds, and there are absorption peaks and absorption peaks and valleys in the 800 n m-1500 nm band.
  • the absorption peak wavelength is the key wavelength, which is the peak wavelength of blood glucose absorption to near-infrared light, which can reflect blood sugar. For the absorption of near-infrared light, the absorption peak-to-valley wavelength is used as the reference wavelength.
  • the photoplethysmographic pulse wave generated by the critical wavelength contains not only the absorption information of the near-infrared light by the blood glucose, but also the absorption information of the near-infrared light by other substances in the blood. Will reference wavelength and off Modeling the bond wavelengths together can effectively reduce the effects of other substances on near-infrared light absorption.
  • another important reason for selecting near-infrared light with a wavelength of less than 1500 nm is that these wavelengths are easily acquired, and some common near-infrared wavelengths, such as typical gallium arsenide diodes, can meet the demand and reduce non-invasive blood glucose. The cost of testing.
  • the feature value extraction module 202 extracts the feature value of the acquired pulse wave signal.
  • the characteristic value of the pulse wave signal may be a magnitude in a unit period of the pulse wave signal, or may be a ratio of a main wave peak to a main wave rising day and a secondary wave main wave relative height.
  • FIG. 4 is a waveform diagram of a pulse wave signal. In one waveform period, the characteristic value is the main peak P of the pulse wave signal, the main trough A, the secondary peak T and the main peak amplitude hP of the secondary trough V, the main valley amplitude hA, the secondary peak amplitude hT, and the secondary valley.
  • the feature value extraction module 202 may extract the characteristic values of the pulse wave signal by using a wavelet transform method: a main peak amplitude hP, a main valley amplitude hA, a secondary peak amplitude hT, a secondary valley amplitude hV, and a main peak.
  • a wavelet transform method a main peak amplitude hP, a main valley amplitude hA, a secondary peak amplitude hT, a secondary valley amplitude hV, and a main peak.
  • Step S34 the initial detection module 203 uses the predicted neural network to detect the characteristic value of the pulse wave signal to obtain an initial detection value of the blood sugar concentration.
  • the initial detection module 203 may perform a first detection on the acquired characteristic value of the pulse wave signal by predicting the neural network, thereby obtaining an initial detection value of the blood glucose concentration.
  • the predictive neural network should be trained first.
  • the training of the predicted neural network may be online or offline. In this embodiment, offline training is preferred, and the standard PPG eigenvalue training signal may be used.
  • the input is the characteristic value of the photoplethysmographic pulse wave, and the corresponding invasively detected blood glucose concentration value (pre-acquired blood glucose sample value) is used as an output, and then the predicted neural network is trained using, for example, a MATLAB neural network.
  • Step S35 the interval detecting module 204 detects the characteristic value of the pulse wave signal by using the classification neural network to obtain a detection interval to which the blood glucose concentration belongs.
  • the interval detecting module 204 may perform second detection on the acquired pulse wave signal by using a classification neural network to obtain an interval in which the acquired pulse wave signal is located.
  • the blood glucose concentration can be divided into sections [3, 4], [4, 5], [5, 6] ... [24, 25] according to a step size of 1, which will cover the human body.
  • the blood glucose concentration range of 3 to 25 is divided into a plurality of sections.
  • the input is the characteristic value of the photoplethysmographic pulse wave, which will correspond to The blood glucose concentration values are classified.
  • the blood glucose concentration value belongs to the interval [3, 4] and is recorded as the first category, and the interval [4, 5] is recorded as the second category, and the interval [5, 6] is recorded as the third category.
  • the analogy is used as an output until the interval [3, 25] of all blood glucose values that occur during training is included, and then the classification neural network is trained using, for example, the MATLAB neural network.
  • Step S36 the blood glucose level outputting module 205 compares the initial detection value with the detection interval to determine whether the initial detection value belongs to the detection interval. If the initial detection value is in the detection interval, step S37 is performed, then the initial detection value is the blood glucose concentration value carried in the pulse wave signal, and the blood glucose value output module 205 displays the initial detection value on the display screen 23 as the human blood glucose. Concentration value. If the initial detected value is not within the detection interval, step S38 is performed and then the process proceeds to step S32, i.e., the blood glucose level outputting module 205 discards the initial detected value and detects the next pulse wave signal until the initial detected value is within the detection interval.
  • the initial detection value obtained by using the predictive neural network is 4.6, and the detection interval obtained by the classification neural network is [4, 5], the initial detection value belongs to the detection interval; otherwise, if the classification neural network is used
  • the obtained detection interval is [5, 6], [3, 4 domain [9, 10], etc., indicating that the initial detection value does not belong to the detection interval. If the initial detection value is not within the detection interval, if the initial detection value differs greatly from the actual blood glucose concentration value, the initial detection value is discarded and the next pulse wave signal is detected.
  • the feature values of the PPG acquisition signals are extracted and sent to the prediction neural network and the classification neural network for the first detection and the second detection, respectively.
  • the initial detection value blood glucose value R1
  • the detection interval blood glucose interval R2
  • Use R1 to judge the interval to which the blood glucose level belongs. If the interval where R1 belongs to R2, then Rl is considered correct, and the detection result R1 is retained as the blood glucose concentration value of the human body; otherwise, the detection result is considered incorrect, and the detection result R1 is discarded and the next pulse is discarded.
  • the wave signal is detected until the detection result R1 belongs to the interval belonging to R2, and will be used as the blood glucose concentration value of the human body.
  • Such repeated detection can effectively reduce the interference of other components (such as moisture) on the blood glucose concentration, and improve the accuracy of blood glucose concentration detection. And accuracy.
  • FIG. 5 is a detailed flowchart of extracting the characteristic values of the pulse wave signals in step S33 in FIG.
  • the feature value extraction module 202 extracts the feature values of the pulse wave signal by means of wavelet transform, and the following steps are as follows:
  • Step S331 the feature value extraction module 202 performs wavelet transform on the acquired pulse wave signal to obtain a wavelet transform sequence.
  • the obtained pulse wave signal for example, PPG signal
  • Noise processing then the smooth wavelet transform is performed on the pure signal after denoising, and the wavelet transform sequence is obtained according to the obtained value after stationary wavelet transform.
  • Step S332 the feature value extraction module 202 searches the wavelet transform sequence for the modulus maxima that meets the preset threshold according to the preset threshold. After obtaining the wavelet transform sequence, a suitable preset threshold may be determined to find a modulus maxima that meets a preset threshold.
  • the modulus maxima in the wavelet transform sequence includes a positive modulus maxima, a negative The modulus maxima and associated submodule maxima.
  • Step S333 the feature value extraction module 202 extracts the feature value of the pulse wave signal according to the modulus maximum value.
  • the characteristic values of the pulse wave signal include a main peak amplitude hP, a main valley amplitude hA, a secondary peak amplitude hT, a secondary valley amplitude hV, and according to the main peak P, the main trough A
  • the position of the secondary peak T and the secondary trough V is obtained as an eigenvalue main peak-sub-valley interval 11, a main peak-sub-peak inter-turn interval t2, a main peak-main valley inter-turn interval t3, and an adjacent main peak inter-turn interval t4.
  • the portable non-invasive blood glucose detecting apparatus and method disclosed in the present embodiment obtains a blood glucose concentration by detecting a pulse wave signal obtained by using a predicted neural network to detect a pulse wave signal obtained by using a predictive neural network. Whether the initial detection value belongs to the detection interval, and when the initial detection value is within the detection interval, the initial detection value is a blood glucose concentration value, and by determining the interval to which the initial detection value belongs, the other components can effectively reduce the blood glucose. The interference caused by the concentration improves the accuracy and accuracy of blood glucose concentration detection.
  • the portable non-invasive blood glucose detecting apparatus and method of the present invention uses a pulse wave signal obtained by predicting a neural network to obtain a detection interval to which a blood glucose concentration belongs, and determines a pulse wave signal acquired by the classification neural network. Obtaining whether the initial detection value of the blood glucose concentration belongs to the detection interval, and when the initial detection value is within the detection interval, the initial detection value is the blood glucose concentration value, and the initial detection is performed by Judging the range to which the value belongs can effectively reduce the interference of other components in the human blood on the blood glucose concentration, and improve the accuracy and accuracy of the blood glucose concentration detection.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Emergency Medicine (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

Provided are a portable device and method for non-invasive blood glucose detection, the method comprising the following steps: a signal processing circuit (3) controlling an infrared light source (13) to emit near infrared light to radiate at a portion to be detected of a human body; a photoelectric sensor (14) acquiring, from the portion to be detected of the human body, a pulse wave signal, and sending same to the signal processing circuit (3) for signal pre-processing (S31); acquiring the pulse wave signal from the signal processing circuit (3) (S32), and extracting a feature value of the acquired pulse wave signal (S33); using a neural prediction network to detect the feature value of the pulse wave signal, so as to obtain an original detection value of the blood glucose concentration (S34); using a neural classification network to detect the feature value of the pulse wave signal, so as to obtain a detection range of the blood glucose concentration (S35); determining whether the original detection value is within the detection range (S36); and if the original detection value is within the detection range, displaying the original detection value on a display screen (23) as a blood glucose concentration value of the human body (S37). The method can effectively reduce the disturbance on the blood glucose concentration caused by the other components of human body blood, and can improve the accuracy of the blood glucose concentration detection.

Description

技术领域  Technical field
[0001] 本发明涉及无创血糖检测技术领域, 尤其涉及一种便携式无创血糖检测设备及 方法。  [0001] The present invention relates to the field of non-invasive blood glucose detecting technology, and in particular to a portable non-invasive blood glucose detecting device and method.
背景技术  Background technique
[0002] 随着社会经济的发展, 糖尿病已经成为现代社会危害人类健康的主要疾病之一 。 血糖的过高或过低, 不仅影响患者的新陈代谢, 还有一些并发症, 像心血管 疾病和神经病变, 这些对于患者的身体健康有着很大的威胁。 根据世界卫生组 织的报告, 到 2035年全世界将会有 3亿糖尿病患者, 其中, 中国的糖尿病患者也 将会有很大一部分。 近年来, 糖尿病的患者不仅存在于一些老年人当中, 对于 一些年轻人, 也幵始出现糖尿病病症。 糖尿病是一种慢性疾病, 很难通过一次 性的治疗达到很好的效果, 所以糖尿病患者需要实吋准确的了解自己的血糖水 平。  [0002] With the development of social economy, diabetes has become one of the major diseases that endanger human health in modern society. Hyperglycemia is too high or too low to affect not only the patient's metabolism, but also some complications, such as cardiovascular disease and neuropathy, which pose a great threat to the health of patients. According to the World Health Organization report, there will be 300 million people with diabetes worldwide by 2035, and a large proportion of people with diabetes in China will also be present. In recent years, patients with diabetes have not only existed in some elderly people, but also in some young people. Diabetes is a chronic disease that is difficult to achieve with a single treatment, so people with diabetes need to know exactly what their blood sugar levels are.
[0003] 但是目前对于血糖检测的方法, 在医院或者患者自己在家中, 都是采用有创的 血糖检测方法, 即直接抽取患者血液, 根据电化学的方法检测患者的血糖水平 。 这种检测方法对患者造成一定的生理痛苦, 而且反复抽血容易造成感染。 进 一步, 电化学反应试纸价格昂贵, 对于糖尿病患者而言, 也是一种较大的经济 负担。 无创血糖检测可消除患者检测的痛苦, 可频繁检测, 改善患者生活质量  [0003] However, at present, for the blood glucose detecting method, in the hospital or the patient's own home, an invasive blood glucose detecting method is adopted, that is, the patient's blood is directly taken, and the blood sugar level of the patient is detected according to an electrochemical method. This method of detection causes certain physical pain to the patient, and repeated blood draws are likely to cause infection. Further, electrochemical reaction test papers are expensive, and are also a large economic burden for diabetic patients. Non-invasive blood glucose testing can eliminate the pain of patient detection, can be frequently detected, improve the quality of life of patients
[0004] 目前, 存在许多无创血糖检测方法, 其中基于红外光的对人体血液中葡萄糖浓 度的检测方法被广泛应用于无创血糖检测的研究中。 然而血液中除了葡萄糖还 存在许多其他成分, 限制了血糖检测的精度。 如何提高血糖检测的精度成为亟 待解决的问题。 [0004] At present, there are many non-invasive blood glucose detecting methods, and infrared light-based methods for detecting glucose concentration in human blood are widely used in the research of non-invasive blood glucose detecting. However, there are many other components in the blood other than glucose, which limits the accuracy of blood glucose detection. How to improve the accuracy of blood glucose detection has become an urgent problem to be solved.
技术问题  technical problem
[0005] 本发明的主要目的在于提供一种便携式无创血糖检测设备及方法, 旨在解决现 有无创血糖检测方法对血糖检测的精度和准确度不高的技术问题。 问题的解决方案 [0005] The main object of the present invention is to provide a portable non-invasive blood glucose detecting device and method, aiming at solving the technical problem that the existing non-invasive blood glucose detecting method has low accuracy and accuracy for blood glucose detecting. Problem solution
技术解决方案  Technical solution
[0006] 为实现上述目的, 本发明提供了一种便携式无创血糖检测设备, 包括信号采集 器和无创血糖检测装置, 所述信号采集器与无创血糖检测装置之间连接有信号 处理电路, 其中:  [0006] In order to achieve the above object, the present invention provides a portable non-invasive blood glucose detecting device, comprising a signal collector and a non-invasive blood glucose detecting device, wherein a signal processing circuit is connected between the signal collector and the non-invasive blood glucose detecting device, wherein:
[0007] 所述信号采集器包括上检测板、 下检测板、 红外光源和光电传感器; 所述红外 光源嵌于上检测板的前端下表面, 用于发射近红外光照射在人体待测部位; 所 述光电传感器嵌于下检测板的前端上表面, 用于从近红外光照射下的人体待测 部位获取脉搏波信号并发送信号处理电路进行信号前置处理;  [0007] The signal collector includes an upper detecting plate, a lower detecting plate, an infrared light source, and a photoelectric sensor; the infrared light source is embedded in a lower surface of the front end of the upper detecting plate, and is configured to emit near-infrared light to be irradiated on a part to be tested; The photoelectric sensor is embedded on the front surface of the front end of the lower detecting plate, and is configured to acquire a pulse wave signal from a portion to be tested of the human body under the illumination of the near-infrared light and send a signal processing circuit to perform signal pre-processing;
[0008] 所述无创血糖检测装置包括微处理器以及存储器, 所述存储器存储有无创血糖 检测系统, 所述无创血糖检测系统由多条指令组成并存储在存储器中, 所述多 条指令由微处理器加载并执行如下步骤: [0008] The non-invasive blood glucose detecting device includes a microprocessor and a memory, wherein the memory stores a non-invasive blood glucose detecting system, wherein the non-invasive blood glucose detecting system is composed of a plurality of instructions and stored in a memory, wherein the plurality of instructions are micro The processor loads and performs the following steps:
[0009] 从信号处理电路获取脉搏波信号, 并提取所获取的脉搏波信号的特征值; [0010] 采用预测神经网络检测脉搏波信号的特征值得到血糖浓度的初始检测值; [0011] 采用分类神经网络检测脉搏波信号的特征值得到血糖浓度的检测区间; Obtaining a pulse wave signal from the signal processing circuit, and extracting a feature value of the acquired pulse wave signal; [0010] using a predictive neural network to detect a characteristic value of the pulse wave signal to obtain an initial detection value of the blood glucose concentration; [0011] The classification neural network detects the characteristic value of the pulse wave signal to obtain a detection interval of the blood glucose concentration;
[0012] 判断初始检测值是否属于检测区间内; [0012] determining whether the initial detection value belongs to the detection interval;
[0013] 当初始检测值在检测区间内吋, 将初始检测值显示在显示屏上作为人体血糖浓 度值。  [0013] When the initial detection value is within the detection interval, the initial detection value is displayed on the display screen as the human blood glucose concentration value.
[0014] 优选的, 所述信号采集器还包括支撑架, 该支撑架的上端设置有滑动槽, 所述 上检测板的一端设置在滑动槽内, 所述下检测板固定在支撑架的下端并与上检 测板轴线平行设置。  [0014] Preferably, the signal collector further includes a support frame, the upper end of the support frame is provided with a sliding slot, one end of the upper detecting board is disposed in the sliding slot, and the lower detecting board is fixed at a lower end of the supporting frame And set parallel to the axis of the upper detection plate.
[0015] 优选的, 所述下检测板的上表面设有铰链机构, 该铰链机构的上端设有复位弹 簧并通过复位弹簧与上检测板连接, 所述铰链机构的下端设有支撑杆并通过该 支撑杆固定在下检测板的上表面。  [0015] Preferably, the upper surface of the lower detecting plate is provided with a hinge mechanism, and the upper end of the hinge mechanism is provided with a return spring and is connected to the upper detecting plate through a return spring, and the lower end of the hinge mechanism is provided with a support rod and passes through The support rod is fixed to the upper surface of the lower detection plate.
[0016] 优选的, 所述下检测板的前端上表面还设置有检测部, 该检测部用于放置人体 待测部位, 所述光电传感器设置在所述检测部内。 [0016] Preferably, the front surface of the front end of the lower detecting plate is further provided with a detecting portion for placing a portion to be tested of the human body, and the photoelectric sensor is disposed in the detecting portion.
[0017] 优选的, 所述红外光源至少包括 800nm-1500nm波段内的多个近红外发光管, 用于向人体待测部位发射至少包括 800nm-l500nm波段的近红外光信号。 [0018] 此外, 本发明还提供一种无创血糖检测方法, 应用于便携式无创血糖检测设备 中, 所述无创血糖检测方法包括步骤: [0017] Preferably, the infrared light source comprises at least a plurality of the near-infrared light emitting tube 800 n m-1500nm band, a human body part to be measured for transmitting at least a near infrared light comprises 800nm -l 500nm band signal. [0018] In addition, the present invention also provides a non-invasive blood glucose detecting method, which is applied to a portable non-invasive blood glucose detecting device, and the non-invasive blood glucose detecting method includes the steps of:
[0019] 信号处理电路控制红外光源发射近红外光照射在人体待测部位; [0019] The signal processing circuit controls the infrared light source to emit near-infrared light to be irradiated on the part to be tested;
[0020] 光电传感器从人体待测部位获取脉搏波信号并发送至信号处理电路; [0020] The photoelectric sensor acquires a pulse wave signal from a portion to be tested of the human body and transmits the pulse wave signal to the signal processing circuit;
[0021] 信号处理电路对脉搏波信号进行信号前置处理; [0021] the signal processing circuit performs signal pre-processing on the pulse wave signal;
[0022] 无创血糖检测装置从信号处理电路获取脉搏波信号, 并提取所获取的脉搏波信 号的特征值;  [0022] The non-invasive blood glucose detecting device acquires a pulse wave signal from the signal processing circuit, and extracts a feature value of the acquired pulse wave signal;
[0023] 无创血糖检测装置采用预测神经网络检测脉搏波信号的特征值得到血糖浓度的 初始检测值;  [0023] The non-invasive blood glucose detecting device uses the predicted neural network to detect the characteristic value of the pulse wave signal to obtain an initial detected value of the blood glucose concentration;
[0024] 无创血糖检测装置采用分类神经网络检测脉搏波信号的特征值得到血糖浓度的 检测区间;  [0024] The non-invasive blood glucose detecting device uses a classification neural network to detect a characteristic value of the pulse wave signal to obtain a detection interval of the blood glucose concentration;
[0025] 无创血糖检测装置判断初始检测值是否属于检测区间内;  [0025] The non-invasive blood glucose detecting device determines whether the initial detected value belongs to the detection interval;
[0026] 如果初始检测值在检测区间内, 无创血糖检测装置则将初始检测值显示在显示 屏上作为人体血糖浓度值。  [0026] If the initial detection value is within the detection interval, the non-invasive blood glucose detecting device displays the initial detection value on the display screen as the human blood glucose concentration value.
[0027] 优选的, 所述无创血糖检测方法包括步骤还包括步骤: 如果初始检测值不在检 测区间内, 无创血糖检测装置则舍弃该初始检测值并对下一个脉搏波信号进行 检测直到初始检测值在检测区间内为止。 [0027] Preferably, the non-invasive blood glucose detecting method comprises the steps of: further comprising: if the initial detection value is not in the detection interval, the non-invasive blood glucose detecting device discards the initial detection value and detects the next pulse wave signal until the initial detection value Until the detection interval.
[0028] 优选的, 所述信号处理电路对脉搏波信号进行信号前置处理的步骤包括如下步 骤: 对脉搏波信号进行滤波去除脉搏波信号中的噪声和直流分量, 留下所需的 交流分量; 对脉搏波信号进行放大和模数转换以得到脉搏波信号的数字信号, 并将该数字信号发送给无创血糖检测装置。 [0028] Preferably, the step of the signal processing circuit performing signal pre-processing on the pulse wave signal comprises the following steps: filtering the pulse wave signal to remove noise and DC components in the pulse wave signal, leaving a required AC component Amplifying and analog-to-digital converting the pulse wave signal to obtain a digital signal of the pulse wave signal, and transmitting the digital signal to the non-invasive blood glucose detecting device.
[0029] 优选的, 所述红外光源至少包括 800nm-1500nm波段内的多个近红外发光管, 用于向人体待测部位发射至少包括 800nm-1500nm波段的近红外光。 [0029] Preferably, the infrared light source comprises at least a plurality of near-infrared light-emitting tubes in a wavelength range of 800 n m to 1500 nm, and is configured to emit near-infrared light including a band of 800 n m to 1500 nm to a portion to be tested of the human body.
[0030] 优选的, 所述无创血糖检测方法包括步骤还包括步骤: 还包括步骤: 无创血糖 检测装置将预设波段内每一次采集到多个脉搏波信号进行检测以得到多个血糖 检测结果; 无创血糖检测装置对多个血糖检测结果去掉最大值和最小值后计算 同一次血糖检测结果的平均值, 并将该将平均值作为最终的人体血糖浓度值。 发明的有益效果 有益效果 [0030] Preferably, the non-invasive blood glucose detecting method comprises the steps of: further comprising the steps of: the non-invasive blood glucose detecting device detects each time a plurality of pulse wave signals are collected in the preset frequency band to obtain a plurality of blood glucose detecting results; The non-invasive blood glucose detecting device calculates the average value of the same blood glucose detecting result after removing the maximum value and the minimum value from the plurality of blood sugar detecting results, and uses the average value as the final human blood sugar concentration value. Advantageous effects of the invention Beneficial effect
[0031] 相较于现有技术, 本发明所述便携式无创血糖检测设备及方法采用预测神经网 络检测获取的脉搏波信号得到血糖浓度所属的检测区间, 并判断分类神经网络 检测获取的脉搏波信号得到血糖浓度的初始检测值是否属于检测区间, 当初始 检测值在所述检测区间内吋, 则该初始检测值为血糖浓度值, 通过对初始检测 值所属区间进行判断, 能够有效地减小人体血液中其它成分对血糖浓度造成的 干扰, 提高了血糖浓度检测的精度和准确度。  Compared with the prior art, the portable non-invasive blood glucose detecting device and method of the present invention uses a pulse wave signal obtained by predicting a neural network to obtain a detection interval to which a blood glucose concentration belongs, and determines a pulse wave signal obtained by the classification neural network. Obtaining whether the initial detection value of the blood glucose concentration belongs to the detection interval, and when the initial detection value is within the detection interval, the initial detection value is a blood glucose concentration value, and by determining the interval to which the initial detection value belongs, the human body can be effectively reduced. The interference of other components in the blood on blood glucose concentration improves the accuracy and accuracy of blood glucose concentration detection.
对附图的简要说明  Brief description of the drawing
附图说明  DRAWINGS
[0032] 图 1是本发明便携式无创血糖检测设备优选实施例的结构示意图;  1 is a schematic structural view of a preferred embodiment of a portable non-invasive blood glucose detecting device of the present invention;
[0033] 图 2是本发明便携式无创血糖检测设备中的无创血糖检测装置的结构示意图; 2 is a schematic structural view of a non-invasive blood glucose detecting device in the portable non-invasive blood glucose detecting device of the present invention;
[0034] 图 3是本发明无创血糖检测方法优选实施例的流程图; 3 is a flow chart of a preferred embodiment of the non-invasive blood glucose detecting method of the present invention;
[0035] 图 4为脉搏波信号的一种波形示意图;  4 is a waveform diagram of a pulse wave signal;
[0036] 图 5为图 3中步骤 S33的提取脉搏波信号的特征值的细化流程图。  5 is a detailed flowchart of the feature value of the extracted pulse wave signal in step S33 of FIG. 3.
[0037] 本发明目的的实现、 功能特点及优点将结合实施例, 参照附图做进一步说明。  [0037] The implementation, functional features, and advantages of the present invention will be further described with reference to the accompanying drawings.
实施该发明的最佳实施例  BEST MODE FOR CARRYING OUT THE INVENTION
本发明的最佳实施方式  BEST MODE FOR CARRYING OUT THE INVENTION
[0038] 为更进一步阐述本发明为达成预定发明目的所采取的技术手段及功效, 以下结 合附图及较佳实施例, 对本发明的具体实施方式、 结构、 特征及其功效, 详细 说明如下。 应当理解, 此处所描述的具体实施例仅仅用以解释本发明, 并不用 于限定本发明。 The specific embodiments, structures, features and functions of the present invention are described in detail below with reference to the accompanying drawings and preferred embodiments. It is understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
[0039] 参照图 1所示, 图 1是本发明便携式无创血糖检测设备优选实施例的结构示意图 。 在本实施例中, 所述便携式无创血糖检测设备包括信号采集器 1和无创血糖检 测装置 2, 其中: 信号采集器 1用于对待测者进行采集并输出脉搏波信号。 无创 血糖检测装置 2与信号采集器 1连接, 用于对信号采集器 1输出的脉搏波信号 (PP G信号) 进行检测, 以得到待测者的血糖浓度。  Referring to FIG. 1, FIG. 1 is a schematic structural view of a preferred embodiment of a portable non-invasive blood glucose detecting device of the present invention. In the present embodiment, the portable non-invasive blood glucose detecting device comprises a signal collector 1 and a non-invasive blood glucose detecting device 2, wherein: the signal collecting device 1 is configured to collect and output a pulse wave signal. The non-invasive blood glucose detecting device 2 is connected to the signal collector 1 for detecting the pulse wave signal (PP G signal) output from the signal collector 1 to obtain the blood glucose concentration of the test subject.
[0040] 在本实施例中, 所述信号采集器 1包括支撑架 10、 上检测板 11、 下检测板 12、 红外光源 13以及光电传感器 14。 其中, 支撑架 10的上端设置有滑动槽 100、 上检 测板 11的一端与滑动槽 100活动连接, 即上检测板 11可以在滑动槽 100内上下移 动, 从而可以调节上检测板 11与下检测板 12之间的距离, 适合放置不同大小的 人体待测部位进行血糖检测, 提高了设备的使用灵活性和适用性。 下检测板 12 固定在支撑架 10的下端, 并与上检测板 11轴线平行设置。 下检测板 12的上表面 设有铰链机构 16, 该铰链机构 16的两侧设有复位弹簧 17, 并通过复位弹簧 17与 上检测板 11连接。 铰链机构 16的下端设有支撑杆 18, 该铰链机构 16通过支撑杆 1 8固定在下检测板 12的上表面。 [0040] In the present embodiment, the signal collector 1 includes a support frame 10, an upper detection plate 11, a lower detection plate 12, an infrared light source 13, and a photosensor 14. Wherein, the upper end of the support frame 10 is provided with a sliding slot 100, and the upper inspection One end of the measuring plate 11 is movably connected to the sliding slot 100, that is, the upper detecting plate 11 can be moved up and down in the sliding slot 100, so that the distance between the upper detecting plate 11 and the lower detecting plate 12 can be adjusted, and the human body of different sizes can be placed. The blood glucose test is performed at the measurement site, which improves the flexibility and applicability of the device. The lower detecting plate 12 is fixed to the lower end of the support frame 10 and disposed in parallel with the axis of the upper detecting plate 11. The upper surface of the lower detecting plate 12 is provided with a hinge mechanism 16, and both ends of the hinge mechanism 16 are provided with a return spring 17, and are connected to the upper detecting plate 11 by a return spring 17. The lower end of the hinge mechanism 16 is provided with a support rod 18 which is fixed to the upper surface of the lower detecting plate 12 by a support rod 18.
[0041] 在本实施例中, 所述上检测板 11位于铰链机构 16的正上方位置处幵设有螺孔 11 0, 螺孔 110设置有内螺纹。 铰链机构 16的上端固定有螺杆 111, 该螺杆 111的外 表面设置有外螺纹, 螺杆 111穿过螺孔 110且螺杆 111的外螺纹与螺孔 110的内螺 纹相匹配。 由于铰链机构 16通过复位弹簧 17连接至上检测板 11上, 因此使用者 可以手动旋转螺杆 111使上检测板 11上下移动带动复位弹簧 17上下弹升与压缩, 从而可以使上检测板 11沿滑动槽 100上下移动, 因此可以调节上检测板 11与下检 测板 12之间的距离。 在本实施例中, 所述红外光源 13嵌于上检测板 11的前端下 表面, 所述光电传感器 14嵌于下检测板 12的前端上表面, 由于上检测板 11和下 检测板 12平行设置, 因此红外光源 13和光电传感器 14同轴分布设置。  In the embodiment, the upper detecting plate 11 is located at a position directly above the hinge mechanism 16 and is provided with a screw hole 110, and the screw hole 110 is provided with an internal thread. The upper end of the hinge mechanism 16 is fixed with a screw 111. The outer surface of the screw 111 is provided with an external thread, and the screw 111 passes through the screw hole 110 and the external thread of the screw 111 matches the inner thread of the screw hole 110. Since the hinge mechanism 16 is connected to the upper detecting plate 11 through the return spring 17, the user can manually rotate the screw 111 to move the upper detecting plate 11 up and down to bring the return spring 17 up and down and compress, so that the upper detecting plate 11 can be moved along the sliding groove 100. Moving up and down, the distance between the upper detecting plate 11 and the lower detecting plate 12 can be adjusted. In this embodiment, the infrared light source 13 is embedded in the lower surface of the front end of the upper detecting plate 11, and the photoelectric sensor 14 is embedded on the front surface of the front end of the lower detecting plate 12, because the upper detecting plate 11 and the lower detecting plate 12 are arranged in parallel. Therefore, the infrared light source 13 and the photosensor 14 are disposed coaxially.
[0042] 在本实施例中, 所述光电传感器 14设置在检测部 15内, 所述检测部 15设置下检 测板 12的前端上表面, 用于提供血糖浓度检测的场所, 可以用于放置人体待测 部位, 例如人体手指指尖、 耳垂或者手腕等人体毛细血管密集的人体组织; 所 述红外光源 13为近红外发光管, 用于向检测部 15发送至少包括近红外光的光信 号, 作为优选的实施例, 红外光源 13可以包括 800nm-1500nm波段内多个近红外 发光管, 近红外发光管峰值波长偏差为 ±10nm, 辐射功率大于 3mW; 光电传感 器 14用于接收经过检测部 15后的光信号并转化为电信号输出, 在具体实施例中 , 可以对光电传感器 14所接收的波段进行设置, 以使光电传感器 14接收的光信 号波段为近红外光波段, 具体地, 光电传感器 14接收的峰值波长偏差为 ±10nm, 感光电流大于 10uA, 光电传感器 14接收的峰值波长偏差小于 ±10nm。 需要说明 的是, 在优选的实施例中, 当对光电传感器 14所接收的波段进行设置后, 红外 光源 13可以包含其它波段的光信号, 但需要满足红外光源 13所发送的光信号至 少包括近红外光。 In the embodiment, the photosensor 14 is disposed in the detecting portion 15, and the detecting portion 15 is provided with a front surface of the front end of the lower detecting plate 12 for providing a blood sugar concentration detecting place, which can be used for placing the human body. a portion to be tested, such as a human finger capillary tip, an ear lobe, or a wrist, such as a human capillary-dense body tissue; the infrared light source 13 is a near-infrared light emitting tube for transmitting an optical signal including at least near-infrared light to the detecting portion 15 as In a preferred embodiment, the infrared light source 13 may include a plurality of near-infrared light-emitting tubes in the 800 n m-1500 nm band, the peak wavelength deviation of the near-infrared light-emitting tube is ±10 nm, and the radiation power is greater than 3 mW; the photosensor 14 is configured to receive the passing detection portion 15 The subsequent optical signal is converted into an electrical signal output. In a specific embodiment, the wavelength band received by the photosensor 14 can be set such that the optical signal received by the photosensor 14 is in the near-infrared band, specifically, the photoelectric sensor. 14 The peak wavelength deviation received is ±10 nm, the photocurrent is greater than 10 uA, and the peak wavelength deviation received by photosensor 14 is less than ±10. Nm. It should be noted that, in a preferred embodiment, after the wavelength band received by the photosensor 14 is set, the infrared light source 13 may include optical signals of other wavelength bands, but needs to meet the optical signal sent by the infrared light source 13 to Less includes near-infrared light.
[0043] 在优选的实施例中, 在信号采集器 1和无创血糖检测装置 2之间可以连接有信号 处理电路 3。 具体地, 信号处理电路 3通过控制线连接至信号采集器 1的红外光源 13, 并通过信号线连接至信号采集器 1的光电传感器 14以及无创血糖检测装置 2 。 当人体待测部位放置在检测部 15并幵启电源幵关 19吋, 信号处理电路 3控制红 外光源 13幵启并发射近红外光照射在人体待测部位, 通过光电传感器 14从人体 待测部位获取脉搏波信号, 并对脉搏波信号进行信号前置处理。 例如对光电传 感器 14输出的信号进行转换、 前置放大和滤波等。 具体地, 在对脉搏波信号进 行滤波吋, 可以采用滤波器对脉搏波信号进行滤波, 能够去除脉搏波信号中的 噪声和直流分量, 留下所需的交流分量; 对脉搏波信号进行放大和模数转换, 作为例子, 可以采用信号放大器对脉搏波信号进行放大, 采用 12位模数转换器 In a preferred embodiment, a signal processing circuit 3 can be connected between the signal collector 1 and the non-invasive blood glucose detecting device 2. Specifically, the signal processing circuit 3 is connected to the infrared light source 13 of the signal collector 1 through a control line and is connected to the photosensor 14 of the signal collector 1 and the non-invasive blood sugar detecting device 2 through a signal line. When the human body to be tested is placed in the detecting portion 15 and the power source is turned off, the signal processing circuit 3 controls the infrared light source 13 to emit and emits near-infrared light to be irradiated on the body to be tested, and the photoelectric sensor 14 is used to detect the portion from the human body. Acquire the pulse wave signal and perform signal pre-processing on the pulse wave signal. For example, the signal output from the photosensor 14 is converted, preamplified, filtered, and the like. Specifically, after filtering the pulse wave signal, the filter can be used to filter the pulse wave signal, and the noise and DC components in the pulse wave signal can be removed to leave a desired AC component; the pulse wave signal is amplified and Analog-to-digital conversion, as an example, a signal amplifier can be used to amplify the pulse wave signal, using a 12-bit analog-to-digital converter
(ADC) 进行采样, 采样频率例如可以是 1ΚΗζ, 以得到脉搏波信号的数字信号 , 并将该数字信号发送给无创血糖检测装置 2进行后续的处理。 在具体实施例中 , 脉搏波信号可以为光电容积脉搏波信号, 也可以为生物阻抗信号或压力传感 信号。 在本实施例中, 所述光电传感器 14采集的脉搏波信号为光电容积脉搏波 信号 (PPG信号) 。 信号处理电路 3还可以为信号采集器 1 (例如红外光源 13和光 电传感器 14) 提供电源。 优选地, 上检测板 11的上表面还设置有电源幵关 19, 该电源幵关 19通过电源线连接至红外光源 13与信号处理电路 3之间, 用于幵启红 外光源 13发射近红外光, 或者关闭红外光源 13停止发射近红外光。 (ADC) is sampled, and the sampling frequency can be, for example, 1 ΚΗζ to obtain a digital signal of the pulse wave signal, and the digital signal is sent to the non-invasive blood sugar detecting device 2 for subsequent processing. In a specific embodiment, the pulse wave signal may be a photoplethysmographic pulse signal or a bioimpedance signal or a pressure sensing signal. In this embodiment, the pulse wave signal collected by the photosensor 14 is a photoplethysmographic pulse signal (PPG signal). The signal processing circuit 3 can also supply power to the signal collector 1 (e.g., the infrared source 13 and the photosensor 14). Preferably, the upper surface of the upper detecting board 11 is further provided with a power switch 19, which is connected between the infrared light source 13 and the signal processing circuit 3 through a power line, and is used to activate the infrared light source 13 to emit near-infrared light. , or turn off the infrared light source 13 to stop emitting near-infrared light.
[0044] 在本实施例中, 采集 PPG信号选择人体的耳垂或者指尖作为提取 PPG信号的部 位, 将耳垂或者指尖放置信号采集器 1的检测部 15。 指尖和耳垂的血液比较丰富 , 随着心脏的周期性循环, 光电传感器能探测到的光电信号周期性的变化, 为 了得到稳定的光电容积脉搏波, 需要将外界的影响因素降到最低或者变为可控 , 例如环境温度和湿度, 综上而言, 耳垂或者指尖是最为合适的提取 PPG信号的 部位。 经过近红外光谱透射人体皮肤组织或者经过人体皮肤组织反射得到光电 容积脉搏波。  In the present embodiment, the PPG signal is acquired to select the earlobe or fingertip of the human body as a portion for extracting the PPG signal, and the earlobe or fingertip is placed on the detecting portion 15 of the signal collector 1. The blood of the fingertips and the earlobe is relatively abundant. With the periodic circulation of the heart, the photoelectric signal can be detected periodically by the photoelectric sensor. In order to obtain a stable photoplethysmographic pulse wave, the external influence factors need to be minimized or changed. For controllability, such as ambient temperature and humidity, in summary, the earlobe or fingertip is the most suitable site for extracting PPG signals. The photoelectric volume pulse wave is obtained by transmitting the human skin tissue through the near-infrared spectrum or by reflecting the human skin tissue.
[0045] 参考图 2所示, 图 2为无创血糖检测装置 2的结构示意图。 在本实施例中, 所述 无创血糖检测装置 2包括微处理器 21、 存储器 22以及显示屏 23。 所述存储器 21存 储有无创血糖检测系统 20, 该无创血糖检测系统 20由各种指令组成的多个模块 并存储在存储器 22中。 所述无创无创血糖检测系统 20包括, 但不仅限于, 信号 获取模块 201、 特征值提取模块 202、 初始检测模块 203、 区间检测模块 204以及 血糖值输出模块 205。 本发明所称的模块是指一种能够被所述微处理器 20执行并 且能够完成固定功能的一系列计算机程序指令, 其存储在所述存储器 21中。 [0045] Referring to FIG. 2, FIG. 2 is a schematic structural view of the non-invasive blood glucose detecting device 2. In the present embodiment, the non-invasive blood glucose detecting device 2 includes a microprocessor 21, a memory 22, and a display screen 23. The memory 21 is stored A non-invasive blood glucose detecting system 20 is stored, which is composed of a plurality of modules composed of various instructions and stored in the memory 22. The non-invasive non-invasive blood glucose detecting system 20 includes, but is not limited to, a signal acquisition module 201, an eigenvalue extraction module 202, an initial detection module 203, an interval detection module 204, and a blood glucose value output module 205. A module referred to in the present invention refers to a series of computer program instructions executable by the microprocessor 20 and capable of performing a fixed function, which are stored in the memory 21.
[0046] 所述的微处理器 21可以为一种中央处理器 (Central Processing Unit, CPU) 、 微控制器 (MCU) 、 数据处理芯片、 或者具有数据处理功能的信息处理单元。 所述存储器 22可以为一种只读存储单元 ROM, 电可擦写存储单元 EEPROM、 快 闪存储单元 FLASH或固体硬盘等。 所述显示屏 23为一种小尺寸 LCD或 LED显示 单元, 其镶嵌于无创血糖检测装置 2的壳体外表面, 由于显示测量的人体血糖浓 度值。 本实施例将结合图 3、 4和 5具体说明无创血糖检测系统 20中各个模块的功 能。 [0046] The microprocessor 21 may be a central processing unit (CPU), a microcontroller (MCU), a data processing chip, or an information processing unit having a data processing function. The memory 22 can be a read only memory unit ROM, an electrically erasable memory unit EEPROM, a flash memory unit FLASH or a solid state hard disk. The display screen 23 is a small-sized LCD or LED display unit that is mounted on the outer surface of the casing of the non-invasive blood glucose detecting device 2, since the measured blood sugar concentration value of the human body is displayed. This embodiment will specifically illustrate the functions of the various modules in the non-invasive blood glucose detecting system 20 in conjunction with Figs. 3, 4 and 5.
[0047] 参考图 3所示, 是本发明无创血糖检测方法的优选实施例的流程图。 在本实施 例中, 基于上述便携式无创血糖检测设备, 本发明还公幵了一种无创血糖检测 方法, 结合图 1和图 2所示, 该无创血糖检测方法包括如下步骤:  Referring to FIG. 3, there is shown a flow chart of a preferred embodiment of the non-invasive blood glucose detecting method of the present invention. In the present embodiment, based on the portable non-invasive blood glucose detecting device described above, the present invention also discloses a non-invasive blood glucose detecting method. As shown in Figs. 1 and 2, the non-invasive blood glucose detecting method includes the following steps:
[0048] 步骤 S31, 当使用者幵启信号采集器 1的电源幵关 19吋, 信号处理电路 3控制红 外光源 13发射近红外光照射在人体待测部位, 光电传感器 14从人体待测部位获 取脉搏波信号并发送至信号处理电路 3对脉搏波信号进行前置处理。 在本实施例 中, 红外光源 13可以发射 800nm-1500nm波段内多个近红外发光管, 光电传感器 1 4从人体待测部位获取脉搏波信号, 信号处理电路 3从光电传感器 14获取脉搏波 信号, 并对脉搏波信号进行信号转换、 前置放大和滤波等信号处理。 [0048] Step S31, when the user turns on the power of the signal collector 1 , the signal processing circuit 3 controls the infrared light source 13 to emit near-infrared light to be irradiated on the part to be tested, and the photosensor 14 is obtained from the body to be tested. The pulse wave signal is sent to the signal processing circuit 3 for pre-processing the pulse wave signal. In the present embodiment, the infrared light source 13 may emit a plurality of near-infrared light 800 n m-1500nm band tube, the photosensor 14 acquires the pulse wave signals from parts of the body to be measured, the signal processing circuit 3 acquires the pulse wave from the photosensor 14 Signal, and signal processing such as signal conversion, preamplification and filtering of the pulse wave signal.
[0049] 步骤 S32, 信号获取模块 201从信号处理电路 3获取脉搏波信号。 所称脉搏波信 号承载着待测样本血糖浓度信息。 本实施例中, 所称脉搏波信号优选为光电容 积脉搏波信号。 葡萄糖分子式含有多个 0-H、 C-H化学键, 在 800nm-1500nm波段 存在吸收峰值和吸收峰谷, 吸收峰值波长作为关键波长, 该波长是血糖对近红 外光吸收的峰值波长, 能够反映血糖对近红外光的吸收情况, 吸收峰谷波长作 为参考波长。 关键波长产生的光电容积脉搏波不仅包含了血糖对近红外光的吸 收信息, 而且包含血液中的其他物质对近红外光的吸收信息。 将参考波长和关 键波长相结合进行建模, 可以有效地减少其他物质对近红外光吸收的影响。 本 实施例中, 选择波长小于 1500nm的近红外光的另一个重要原因是由于这些波长 容易获取, 都是一些常见的近红外波长, 例如典型的砷化镓二极管就能达到需 求, 降低了无创血糖检测的成本。 [0049] Step S32, the signal acquisition module 201 acquires a pulse wave signal from the signal processing circuit 3. The so-called pulse wave signal carries the blood glucose concentration information of the sample to be tested. In this embodiment, the so-called pulse wave signal is preferably a photoplethysmographic pulse signal. The glucose formula contains multiple 0-H, CH chemical bonds, and there are absorption peaks and absorption peaks and valleys in the 800 n m-1500 nm band. The absorption peak wavelength is the key wavelength, which is the peak wavelength of blood glucose absorption to near-infrared light, which can reflect blood sugar. For the absorption of near-infrared light, the absorption peak-to-valley wavelength is used as the reference wavelength. The photoplethysmographic pulse wave generated by the critical wavelength contains not only the absorption information of the near-infrared light by the blood glucose, but also the absorption information of the near-infrared light by other substances in the blood. Will reference wavelength and off Modeling the bond wavelengths together can effectively reduce the effects of other substances on near-infrared light absorption. In this embodiment, another important reason for selecting near-infrared light with a wavelength of less than 1500 nm is that these wavelengths are easily acquired, and some common near-infrared wavelengths, such as typical gallium arsenide diodes, can meet the demand and reduce non-invasive blood glucose. The cost of testing.
[0050] 步骤 S33, 特征值提取模块 202提取所获取的脉搏波信号的特征值。 在具体实施 例中, 所述脉搏波信号的特征值可以是脉搏波信号单位周期内的幅值, 也可以 是主波波峰与主波上升吋间比值和次波主波相对高度值。 在优选的实施例中, 请参考图 4所示, 图 4为脉搏波信号的一种波形示意图。 在一个波形周期内, 所 述特征值为脉搏波信号的主波峰 P、 主波谷 A、 次波峰 T及次波谷 V的主峰幅值 hP 、 主谷幅值 hA、 次峰幅值 hT、 次谷幅值 hV、 主峰-次谷吋间间隔 tl、 主峰 -次峰 吋间间隔 t2、 主峰-主谷吋间间隔 t3和相邻主峰吋间间隔 t4。 在具体实施例中, 特 征值提取模块 202可以采用小波变换的方式当提取脉搏波信号的特征值: 主峰幅 值 hP、 主谷幅值 hA、 次峰幅值 hT、 次谷幅值 hV、 主峰-次谷吋间间隔 tl、 主峰- 次峰吋间间隔 t2、 主峰-主谷吋间间隔 t3和相邻主峰吋间间隔 t4。  [0050] Step S33, the feature value extraction module 202 extracts the feature value of the acquired pulse wave signal. In a specific embodiment, the characteristic value of the pulse wave signal may be a magnitude in a unit period of the pulse wave signal, or may be a ratio of a main wave peak to a main wave rising day and a secondary wave main wave relative height. In a preferred embodiment, please refer to FIG. 4, which is a waveform diagram of a pulse wave signal. In one waveform period, the characteristic value is the main peak P of the pulse wave signal, the main trough A, the secondary peak T and the main peak amplitude hP of the secondary trough V, the main valley amplitude hA, the secondary peak amplitude hT, and the secondary valley. The amplitude hV, the main peak-sub-valley interval tl, the main peak-second peak interval t2, the main peak-main valley inter-turn interval t3, and the adjacent main peak inter-turn interval t4. In a specific embodiment, the feature value extraction module 202 may extract the characteristic values of the pulse wave signal by using a wavelet transform method: a main peak amplitude hP, a main valley amplitude hA, a secondary peak amplitude hT, a secondary valley amplitude hV, and a main peak. - Inter-valley interval tl, main peak-sub-peak interval t2, main peak-main valley inter-turn interval t3, and adjacent main peak inter-turn interval t4.
[0051] 步骤 S34, 初始检测模块 203采用预测神经网络检测脉搏波信号的特征值得到血 糖浓度的初始检测值。 在具体实施例中, 初始检测模块 203可以通过预测神经网 络对获取的脉搏波信号的特征值进行第一检测, 从而得到血糖浓度的初始检测 值。 在具体实施吋, 应首先对预测神经网络进行训练, 预测神经网络的训练可 以是在线的, 也可以是离线的, 本实施例中, 优选为离线训练, 可以采用标准 的 PPG特征值训练信号进行训练, 对于预测神经网络, 输入是光电容积脉搏波的 特征值, 将对应的有创检测血糖浓度值 (预先采集的血糖样本值) 作为输出, 然后使用例如 MATLAB神经网络进行训练出预测神经网络。  [0051] Step S34, the initial detection module 203 uses the predicted neural network to detect the characteristic value of the pulse wave signal to obtain an initial detection value of the blood sugar concentration. In a specific embodiment, the initial detection module 203 may perform a first detection on the acquired characteristic value of the pulse wave signal by predicting the neural network, thereby obtaining an initial detection value of the blood glucose concentration. In the specific implementation, the predictive neural network should be trained first. The training of the predicted neural network may be online or offline. In this embodiment, offline training is preferred, and the standard PPG eigenvalue training signal may be used. Training, For predictive neural networks, the input is the characteristic value of the photoplethysmographic pulse wave, and the corresponding invasively detected blood glucose concentration value (pre-acquired blood glucose sample value) is used as an output, and then the predicted neural network is trained using, for example, a MATLAB neural network.
[0052] 步骤 S35, 区间检测模块 204采用分类神经网络检测脉搏波信号的特征值得到血 糖浓度所属的检测区间。 在具体实施例中, 区间检测模块 204可以通过分类神经 网络来对获取的脉搏波信号进行第二检测, 以得到获取的脉搏波信号所在的区 间。 具体地, 以人体为例, 血糖浓度可以按照步长为 1进行划分分类区间 [3, 4] 、 [4, 5]、 [5, 6] ...[24, 25], 从而将涵盖人体血糖浓度范围 3〜25划分成了多个 区间。 对分类神经网络进行训练中, 输入是光电容积脉搏波的特征值, 将对应 的血糖浓度值进行分类, 如血糖浓度值属于区间 [3, 4]记为第一类, 属于区间 [4 , 5]记为第二类, 属于区间 [5, 6]记为第三类, 以此类推作为输出, 直到将训练 过程中出现的所有血糖值的区间 [3, 25]包含在内, 然后使用例如 MATLAB神经 网络进行训练出分类神经网络。 [0052] Step S35, the interval detecting module 204 detects the characteristic value of the pulse wave signal by using the classification neural network to obtain a detection interval to which the blood glucose concentration belongs. In a specific embodiment, the interval detecting module 204 may perform second detection on the acquired pulse wave signal by using a classification neural network to obtain an interval in which the acquired pulse wave signal is located. Specifically, taking the human body as an example, the blood glucose concentration can be divided into sections [3, 4], [4, 5], [5, 6] ... [24, 25] according to a step size of 1, which will cover the human body. The blood glucose concentration range of 3 to 25 is divided into a plurality of sections. In the training of the classification neural network, the input is the characteristic value of the photoplethysmographic pulse wave, which will correspond to The blood glucose concentration values are classified. For example, the blood glucose concentration value belongs to the interval [3, 4] and is recorded as the first category, and the interval [4, 5] is recorded as the second category, and the interval [5, 6] is recorded as the third category. The analogy is used as an output until the interval [3, 25] of all blood glucose values that occur during training is included, and then the classification neural network is trained using, for example, the MATLAB neural network.
[0053] 步骤 S36, 血糖值输出模块 205将初始检测值与检测区间进行比对判断初始检测 值是否属于检测区间内。 如果初始检测值在检测区间内, 则执行步骤 S37, 则该 初始检测值则为脉搏波信号中承载的血糖浓度值, 则血糖值输出模块 205将初始 检测值显示在显示屏 23上作为人体血糖浓度值。 如果初始检测值不在检测区间 内, 则执行步骤 S38而后转向步骤 S32, 即血糖值输出模块 205舍弃初始检测值并 对下一个脉搏波信号进行检测直到初始检测值在检测区间内为止。 举例子来讲 , 譬如采用预测神经网络得到的初始检测值为 4.6, 采用分类神经网络得到的检 测区间为 [4, 5], 则说明初始检测值属于该检测区间; 反之, 如果采用分类神经 网络得到的检测区间为 [5, 6]、 [3, 4域 [9, 10]等, 则说明初始检测值不属于该 检测区间内。 如果初始检测值不在检测区间内, 则该初始检测值与实际的血糖 浓度值相差较大, 则舍弃该初始检测值并对下一个脉搏波信号进行检测。  [0053] Step S36, the blood glucose level outputting module 205 compares the initial detection value with the detection interval to determine whether the initial detection value belongs to the detection interval. If the initial detection value is in the detection interval, step S37 is performed, then the initial detection value is the blood glucose concentration value carried in the pulse wave signal, and the blood glucose value output module 205 displays the initial detection value on the display screen 23 as the human blood glucose. Concentration value. If the initial detected value is not within the detection interval, step S38 is performed and then the process proceeds to step S32, i.e., the blood glucose level outputting module 205 discards the initial detected value and detects the next pulse wave signal until the initial detected value is within the detection interval. For example, if the initial detection value obtained by using the predictive neural network is 4.6, and the detection interval obtained by the classification neural network is [4, 5], the initial detection value belongs to the detection interval; otherwise, if the classification neural network is used The obtained detection interval is [5, 6], [3, 4 domain [9, 10], etc., indicating that the initial detection value does not belong to the detection interval. If the initial detection value is not within the detection interval, if the initial detection value differs greatly from the actual blood glucose concentration value, the initial detection value is discarded and the next pulse wave signal is detected.
[0054] 在本实施例中, 提取 PPG采集信号的特征值, 并分别送入预测神经网络和分类 神经网络进行第一检测和第二检测。 利用预测神经网络进行第一检测得到初始 检测值 (血糖值 R1), 利用分类神经网络进行第二检测得到检测区间 (血糖区间 R2) 。 利用 R1判断血糖值所属区间, 如果 R1所在区间属于 R2, 那么则认为 Rl是正确 的, 保留检测结果 R1作为人体血糖浓度值; 反之, 则认为检测结果错误, 丢弃 检测结果 R1并对下一个脉搏波信号进行检测直到检测结果 R1属于区间属于 R2内 , 将作为人体血糖浓度值, 如此反复检测能够有效地减小其它成分 (例如水分 等) 对血糖浓度造成的干扰, 提高了血糖浓度检测的精度和准确度。  [0054] In this embodiment, the feature values of the PPG acquisition signals are extracted and sent to the prediction neural network and the classification neural network for the first detection and the second detection, respectively. The initial detection value (blood glucose value R1) is obtained by the first detection using the predictive neural network, and the detection interval (blood glucose interval R2) is obtained by the second detection using the classification neural network. Use R1 to judge the interval to which the blood glucose level belongs. If the interval where R1 belongs to R2, then Rl is considered correct, and the detection result R1 is retained as the blood glucose concentration value of the human body; otherwise, the detection result is considered incorrect, and the detection result R1 is discarded and the next pulse is discarded. The wave signal is detected until the detection result R1 belongs to the interval belonging to R2, and will be used as the blood glucose concentration value of the human body. Such repeated detection can effectively reduce the interference of other components (such as moisture) on the blood glucose concentration, and improve the accuracy of blood glucose concentration detection. And accuracy.
[0055] 如图 5所示, 图 5为图 3中的步骤 S33提取脉搏波信号的特征值的细化流程图。 具 体地, 特征值提取模块 202采用小波变换的方式提取脉搏波信号的特征值包括如 下步骤:  As shown in FIG. 5, FIG. 5 is a detailed flowchart of extracting the characteristic values of the pulse wave signals in step S33 in FIG. Specifically, the feature value extraction module 202 extracts the feature values of the pulse wave signal by means of wavelet transform, and the following steps are as follows:
[0056] 步骤 S331, 特征值提取模块 202对获取的脉搏波信号进行小波变换得到小波变 换序列。 在小波变换之前, 可以首先对获得的脉搏波信号 (例如 PPG信号)进行去 噪处理, 再对消噪后的纯净信号进行平稳小波变换, 平稳小波变换后根据所得 值得到小波变换序列。 [0056] Step S331, the feature value extraction module 202 performs wavelet transform on the acquired pulse wave signal to obtain a wavelet transform sequence. Before the wavelet transform, the obtained pulse wave signal (for example, PPG signal) can be first performed. Noise processing, then the smooth wavelet transform is performed on the pure signal after denoising, and the wavelet transform sequence is obtained according to the obtained value after stationary wavelet transform.
[0057] 步骤 S332, 特征值提取模块 202根据预设阈值在小波变换序列中査找符合预设 阈值的模极大值。 在得到小波变换序列之后, 可以确定合适的预设阈值, 以査 找符合预设阈值的模极大值, 在本实施中, 小波变换序列中的模极大值包括正 的模极大值、 负的模极大值和相关的次模极大值。  [0057] Step S332, the feature value extraction module 202 searches the wavelet transform sequence for the modulus maxima that meets the preset threshold according to the preset threshold. After obtaining the wavelet transform sequence, a suitable preset threshold may be determined to find a modulus maxima that meets a preset threshold. In this implementation, the modulus maxima in the wavelet transform sequence includes a positive modulus maxima, a negative The modulus maxima and associated submodule maxima.
[0058] 步骤 S333, 特征值提取模块 202根据模极大值提取脉搏波信号的特征值。 在本 实例中, 如图 4所示, 脉搏波信号的特征值包括主峰幅值 hP、 主谷幅值 hA、 次峰 幅值 hT、 次谷幅值 hV, 并根据主波峰 P、 主波谷 A、 次波峰 T及次波谷 V的位置得 到特征值主峰-次谷吋间间隔 11、 主峰-次峰吋间间隔 t2、 主峰-主谷吋间间隔 t3和 相邻主峰吋间间隔 t4。  [0058] Step S333, the feature value extraction module 202 extracts the feature value of the pulse wave signal according to the modulus maximum value. In this example, as shown in FIG. 4, the characteristic values of the pulse wave signal include a main peak amplitude hP, a main valley amplitude hA, a secondary peak amplitude hT, a secondary valley amplitude hV, and according to the main peak P, the main trough A The position of the secondary peak T and the secondary trough V is obtained as an eigenvalue main peak-sub-valley interval 11, a main peak-sub-peak inter-turn interval t2, a main peak-main valley inter-turn interval t3, and an adjacent main peak inter-turn interval t4.
[0059] 本实施例公幵的便携式无创血糖检测设备及方法, 由于采用预测神经网络检测 获取的脉搏波信号得到血糖浓度所属的检测区间, 并判断分类神经网络检测获 取的脉搏波信号得到血糖浓度的初始检测值是否属于检测区间, 当初始检测值 在所述检测区间内吋, 则该初始检测值为血糖浓度值, 通过对初始检测值所属 区间进行判断, 能够有效地减小其它成分对血糖浓度造成的干扰, 提高了血糖 浓度检测的精度和准确度。  [0059] The portable non-invasive blood glucose detecting apparatus and method disclosed in the present embodiment obtains a blood glucose concentration by detecting a pulse wave signal obtained by using a predicted neural network to detect a pulse wave signal obtained by using a predictive neural network. Whether the initial detection value belongs to the detection interval, and when the initial detection value is within the detection interval, the initial detection value is a blood glucose concentration value, and by determining the interval to which the initial detection value belongs, the other components can effectively reduce the blood glucose. The interference caused by the concentration improves the accuracy and accuracy of blood glucose concentration detection.
[0060] 本领域技术人员可以理解, 上述实施方式中各种方法的全部或部分步骤可以通 过程序来指令相关硬件完成, 该程序可以存储于计算机可读存储介质中, 存储 介质可以包括: 只读存储器、 随机存储器、 磁盘或光盘等。  [0060] Those skilled in the art may understand that all or part of the steps of the various methods in the above embodiments may be completed by a program to instruct related hardware, and the program may be stored in a computer readable storage medium, and the storage medium may include: Memory, random access memory, disk or CD, etc.
[0061] 以上仅为本发明的优选实施例, 并非因此限制本发明的专利范围, 凡是利用本 发明说明书及附图内容所作的等效结构或等效流程变换, 或直接或间接运用在 其他相关的技术领域, 均同理包括在本发明的专利保护范围内。  The above are only the preferred embodiments of the present invention, and are not intended to limit the scope of the invention, and the equivalent structure or equivalent process transformations made by the description of the invention and the drawings are directly or indirectly applied to other related The technical field is equally included in the scope of patent protection of the present invention.
工业实用性  Industrial applicability
[0062] 相较于现有技术, 本发明所述便携式无创血糖检测设备及方法采用预测神经网 络检测获取的脉搏波信号得到血糖浓度所属的检测区间, 并判断分类神经网络 检测获取的脉搏波信号得到血糖浓度的初始检测值是否属于检测区间, 当初始 检测值在所述检测区间内吋, 则该初始检测值为血糖浓度值, 通过对初始检测 值所属区间进行判断, 能够有效地减小人体血液中其它成分对血糖浓度造成的 干扰, 提高了血糖浓度检测的精度和准确度。 Compared with the prior art, the portable non-invasive blood glucose detecting apparatus and method of the present invention uses a pulse wave signal obtained by predicting a neural network to obtain a detection interval to which a blood glucose concentration belongs, and determines a pulse wave signal acquired by the classification neural network. Obtaining whether the initial detection value of the blood glucose concentration belongs to the detection interval, and when the initial detection value is within the detection interval, the initial detection value is the blood glucose concentration value, and the initial detection is performed by Judging the range to which the value belongs can effectively reduce the interference of other components in the human blood on the blood glucose concentration, and improve the accuracy and accuracy of the blood glucose concentration detection.

Claims

权利要求书 Claim
[权利要求 1] 一种便携式无创血糖检测设备, 其特征在于, 包括信号采集器和无创 血糖检测装置, 所述信号采集器与无创血糖检测装置之间连接有信号 处理电路, 其中: 所述信号采集器包括上检测板、 下检测板、 红外光 源和光电传感器; 所述红外光源嵌于上检测板的前端下表面, 用于发 射近红外光照射在人体待测部位; 所述光电传感器嵌于下检测板的前 端上表面, 用于从近红外光照射下的人体待测部位获取脉搏波信号并 发送信号处理电路进行信号前置处理; 所述无创血糖检测装置包括微 处理器以及存储器, 所述存储器存储有无创血糖检测系统, 所述无创 血糖检测系统由多条指令组成并存储在存储器中, 所述多条指令由微 处理器加载并执行如下步骤: 从信号处理电路获取脉搏波信号, 并提 取所获取的脉搏波信号的特征值; 采用预测神经网络检测脉搏波信号 的特征值得到血糖浓度的初始检测值; 采用分类神经网络检测脉搏波 信号的特征值得到血糖浓度的检测区间; 判断初始检测值是否属于检 测区间内; 当初始检测值在检测区间内吋, 将初始检测值显示在显示 屏上作为人体血糖浓度值。  [Claim 1] A portable non-invasive blood glucose detecting device, comprising: a signal collector and a non-invasive blood glucose detecting device, wherein a signal processing circuit is connected between the signal collector and the non-invasive blood glucose detecting device, wherein: the signal The collector includes an upper detecting plate, a lower detecting plate, an infrared light source and a photoelectric sensor; the infrared light source is embedded in a lower surface of the front end of the upper detecting plate, and is configured to emit near-infrared light to be irradiated on a part to be tested; the photoelectric sensor is embedded in The front surface of the front end of the lower detecting plate is configured to acquire a pulse wave signal from a portion to be tested of the human body irradiated by near-infrared light and send a signal processing circuit to perform signal pre-processing; the non-invasive blood glucose detecting device includes a microprocessor and a memory, The memory stores a non-invasive blood glucose detecting system, the non-invasive blood glucose detecting system is composed of a plurality of instructions and stored in a memory, the plurality of instructions being loaded by the microprocessor and performing the following steps: acquiring a pulse wave signal from the signal processing circuit, And extracting the characteristic value of the acquired pulse wave signal; The neural network detects the characteristic value of the pulse wave signal to obtain the initial detection value of the blood glucose concentration; uses the classification neural network to detect the characteristic value of the pulse wave signal to obtain the detection interval of the blood glucose concentration; determines whether the initial detection value belongs to the detection interval; when the initial detection value is Within the detection interval, the initial detection value is displayed on the display as the blood glucose concentration value of the human body.
[权利要求 2] 如权利要求 1所述的便携式无创血糖检测设备, 其特征在于, 所述信 号采集器还包括支撑架, 该支撑架的上端设置有滑动槽, 所述上检测 板的一端设置在滑动槽内, 所述下检测板固定在支撑架的下端并与上 检测板轴线平行设置。  [Claim 2] The portable non-invasive blood glucose detecting device according to claim 1, wherein the signal collector further comprises a support frame, the upper end of the support frame is provided with a sliding slot, and one end of the upper detecting plate is disposed In the sliding groove, the lower detecting plate is fixed to the lower end of the support frame and disposed in parallel with the axis of the upper detecting plate.
[权利要求 3] 如权利要求 2所述的便携式无创血糖检测设备, 其特征在于, 所述下 检测板的上表面设有铰链机构, 该铰链机构的上端设有复位弹簧并通 过复位弹簧与上检测板连接, 所述铰链机构的下端设有支撑杆并通过 该支撑杆固定在下检测板的上表面。  [Claim 3] The portable non-invasive blood glucose detecting device according to claim 2, wherein the upper surface of the lower detecting plate is provided with a hinge mechanism, and the upper end of the hinge mechanism is provided with a return spring and passes through the return spring and the upper The detecting plate is connected, and the lower end of the hinge mechanism is provided with a supporting rod and is fixed to the upper surface of the lower detecting plate by the supporting rod.
[权利要求 4] 如权利要求 2所述的便携式无创血糖检测设备, 其特征在于, 所述下 检测板的前端上表面还设置有检测部, 该检测部用于放置人体待测部 位, 所述光电传感器设置在所述检测部内。  [Claim 4] The portable non-invasive blood glucose detecting device according to claim 2, wherein the front surface of the front end of the lower detecting plate is further provided with a detecting portion for placing a portion to be tested of the human body, A photosensor is disposed in the detecting portion.
[权利要求 5] 如权利要求 1至 4任一项所述的便携式无创血糖检测设备, 其特征在于 , 所述红外光源至少包括 800nm-1500nm波段内的多个近红外发光管 , 用于向人体待测部位发射至少包括 800nm-1500nm波段的近红外光 [Claim 5] The portable non-invasive blood glucose detecting device according to any one of claims 1 to 4, characterized in that The infrared light source includes at least a plurality of near-infrared light-emitting tubes in a band of 800 n m to 1500 nm, and is configured to emit near-infrared light including a band of 800 n m to 1500 nm to a portion to be tested of a human body.
[权利要求 6] —种无创血糖检测方法, 应用于便携式无创血糖检测设备中, 其特征 在于, 所述便携式无创血糖检测设备包括信号采集器和无创血糖检测 装置, 所述信号采集器与无创血糖检测装置之间连接有信号处理电路 , 所述信号采集器包括红外光源和光电传感器, 其中, 所述无创血糖 检测方法包括步骤: 信号处理电路控制红外光源发射近红外光照射在 人体待测部位; 光电传感器从人体待测部位获取脉搏波信号并发送至 信号处理电路; 信号处理电路对脉搏波信号进行信号前置处理; 无创 血糖检测装置从信号处理电路获取脉搏波信号, 并提取所获取的脉搏 波信号的特征值; 无创血糖检测装置采用预测神经网络检测脉搏波信 号的特征值得到血糖浓度的初始检测值; 无创血糖检测装置采用分类 神经网络检测脉搏波信号的特征值得到血糖浓度的检测区间; 无创血 糖检测装置判断初始检测值是否属于检测区间内; 如果初始检测值在 检测区间内, 无创血糖检测装置则将初始检测值显示在显示屏上作为 人体血糖浓度值。 [Claim 6] A non-invasive blood glucose detecting method for use in a portable non-invasive blood glucose detecting device, characterized in that the portable non-invasive blood glucose detecting device comprises a signal collector and a non-invasive blood glucose detecting device, the signal collector and non-invasive blood glucose A signal processing circuit is connected between the detecting devices, the signal collecting device includes an infrared light source and a photoelectric sensor, wherein the non-invasive blood glucose detecting method comprises the following steps: the signal processing circuit controls the infrared light source to emit near-infrared light to be irradiated on the part to be tested; The photoelectric sensor obtains the pulse wave signal from the part to be tested of the human body and sends it to the signal processing circuit; the signal processing circuit performs signal pre-processing on the pulse wave signal; the non-invasive blood glucose detecting device acquires the pulse wave signal from the signal processing circuit, and extracts the acquired pulse wave The characteristic value of the wave signal; the non-invasive blood glucose detecting device uses the predicted neural network to detect the characteristic value of the pulse wave signal to obtain the initial detection value of the blood glucose concentration; the non-invasive blood glucose detecting device uses the classification neural network to detect the characteristic value of the pulse wave signal to obtain the blood glucose Degree detecting section; non-invasive blood glucose detection means determines whether the detected value is within the initial detection section; if the initial value is detected in the detection zone, then the initial non-invasive blood glucose value detecting means detecting a blood glucose concentration value displayed on the display screen.
[权利要求 7] 如权利要求 6所述的无创血糖检测方法, 其特征在于, 该方法还包括 步骤: 如果初始检测值不在检测区间内, 无创血糖检测装置则舍弃该 初始检测值并对下一个脉搏波信号进行检测直到初始检测值在检测区 间内为止。  [Claim 7] The non-invasive blood glucose detecting method according to claim 6, wherein the method further comprises the step of: if the initial detected value is not within the detection interval, the non-invasive blood glucose detecting device discards the initial detected value and the next one The pulse wave signal is detected until the initial detection value is within the detection interval.
[权利要求 8] 如权利要求 6所述的无创血糖检测方法, 其特征在于, 所述信号处理 电路对脉搏波信号进行信号前置处理的步骤包括如下步骤: 对脉搏波 信号进行滤波去除脉搏波信号中的噪声和直流分量, 留下所需的交流 分量; 对脉搏波信号进行放大和模数转换以得到脉搏波信号的数字信 号, 并将该数字信号发送给无创血糖检测装置。  The non-invasive blood glucose detecting method according to claim 6, wherein the step of performing signal pre-processing on the pulse wave signal by the signal processing circuit comprises the following steps: filtering the pulse wave signal to remove the pulse wave The noise and DC components in the signal leave the desired AC component; the pulse wave signal is amplified and analog-digital converted to obtain a digital signal of the pulse wave signal, and the digital signal is sent to the non-invasive blood glucose detecting device.
[权利要求 9] 如权利要求 6所述的无创血糖检测方法, 其特征在于, 所述无创血糖 检测装置提取所获取的脉搏波信号的特征值的步骤包括如下步骤: 对 所获取的脉搏波信号进行小波变换得到小波变换序列; 根据预设阈值 在小波变换序列中査找符合预设阈值的模极大值; 根据模极大值提取 所述脉搏波信号的特征值。 [Claim 9] The non-invasive blood glucose detecting method according to claim 6, wherein the step of extracting the characteristic value of the acquired pulse wave signal by the non-invasive blood glucose detecting device comprises the following steps: The acquired pulse wave signal is subjected to wavelet transform to obtain a wavelet transform sequence; the modulus maximum value corresponding to the preset threshold is searched in the wavelet transform sequence according to the preset threshold; and the characteristic value of the pulse wave signal is extracted according to the modulus maximum value.
[权利要求 10] 如权利要求 6至 9任一项所述的无创血糖检测方法, 其特征在于, 所述 红外光源至少包括 800nm-1500nm波段内的多个近红外发光管, 用于 向人体待测部位发射至少包括 800nm-1500nm波段的近红外光。 The non-invasive blood glucose detecting method according to any one of claims 6 to 9, wherein the infrared light source comprises at least a plurality of near-infrared light-emitting tubes in a wavelength range of 800 n m to 1500 nm, The human body to be tested emits near-infrared light including at least the 800 nm to 1500 nm band.
PCT/CN2017/098189 2017-05-20 2017-08-19 Portable device and method for non-invasive blood glucose detection WO2018214297A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710360042.XA CN107296616A (en) 2017-05-20 2017-05-20 Portable non-invasive blood sugar test device and method
CN201710360042.X 2017-05-20

Publications (1)

Publication Number Publication Date
WO2018214297A1 true WO2018214297A1 (en) 2018-11-29

Family

ID=60137567

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/098189 WO2018214297A1 (en) 2017-05-20 2017-08-19 Portable device and method for non-invasive blood glucose detection

Country Status (2)

Country Link
CN (1) CN107296616A (en)
WO (1) WO2018214297A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107361776A (en) * 2017-05-20 2017-11-21 深圳市前海安测信息技术有限公司 Noninvasive system for detecting blood sugar and method
CN207949805U (en) * 2017-05-20 2018-10-12 深圳市前海安测信息技术有限公司 Woundless blood sugar data acquisition device
CN110097937B (en) * 2019-05-13 2021-07-06 深圳六合六医疗器械有限公司 Personalized blood sugar interval statistical method and device
CN110141249B (en) * 2019-06-18 2022-02-18 张远 Non-invasive blood glucose monitoring method, system, equipment and medium based on PPG signal
CN112220449B (en) * 2019-07-15 2023-09-15 爱科维申科技(天津)有限公司 Photoelectric chicken embryo survival detection device and method
CN110575182A (en) * 2019-08-30 2019-12-17 北京信息科技大学 Method and device for detecting blood sugar
CN110974250B (en) * 2019-12-27 2024-01-16 深圳市华讯方舟光电技术有限公司 Terahertz spectrum-based blood glucose detection method and device and computer storage medium
CN111588384B (en) * 2020-05-27 2023-08-22 京东方科技集团股份有限公司 Method, device and equipment for obtaining blood glucose detection result
CN112120711B (en) * 2020-09-22 2023-10-13 博邦芳舟医疗科技(北京)有限公司 Noninvasive diabetes prediction system and method based on photoplethysmography pulse waves
CN115998295B (en) * 2023-03-24 2023-06-09 广东工业大学 Blood fat estimation method, system and device combining far-near infrared light

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3966796B2 (en) * 2002-09-26 2007-08-29 真人 中村 Blood glucose measuring device
CN201519152U (en) * 2009-09-25 2010-07-07 深圳先进技术研究院 Noninvasive blood sugar detecting system
CN102217940A (en) * 2011-06-14 2011-10-19 中国科学院长春光学精密机械与物理研究所 Method for realizing no-wound human blood glucose measuring by utilizing volume pulse wave characteristic value
CN103153175A (en) * 2010-05-14 2013-06-12 先进计算发展中心 Diagnostic classifications of pulse signal waveform data
WO2014104036A1 (en) * 2012-12-24 2014-07-03 Yamaguchi Takashi Wristwatch-type blood sugar level watch device
CN105193423A (en) * 2015-09-25 2015-12-30 北京大学深圳研究生院 Non-invasive blood glucose detection method, device and system
CN205514619U (en) * 2015-12-24 2016-08-31 上海钛全机械工程有限公司 Noninvasive blood glucose sensing device
CN107361776A (en) * 2017-05-20 2017-11-21 深圳市前海安测信息技术有限公司 Noninvasive system for detecting blood sugar and method

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3966796B2 (en) * 2002-09-26 2007-08-29 真人 中村 Blood glucose measuring device
CN201519152U (en) * 2009-09-25 2010-07-07 深圳先进技术研究院 Noninvasive blood sugar detecting system
CN103153175A (en) * 2010-05-14 2013-06-12 先进计算发展中心 Diagnostic classifications of pulse signal waveform data
CN102217940A (en) * 2011-06-14 2011-10-19 中国科学院长春光学精密机械与物理研究所 Method for realizing no-wound human blood glucose measuring by utilizing volume pulse wave characteristic value
WO2014104036A1 (en) * 2012-12-24 2014-07-03 Yamaguchi Takashi Wristwatch-type blood sugar level watch device
CN105193423A (en) * 2015-09-25 2015-12-30 北京大学深圳研究生院 Non-invasive blood glucose detection method, device and system
CN205514619U (en) * 2015-12-24 2016-08-31 上海钛全机械工程有限公司 Noninvasive blood glucose sensing device
CN107361776A (en) * 2017-05-20 2017-11-21 深圳市前海安测信息技术有限公司 Noninvasive system for detecting blood sugar and method

Also Published As

Publication number Publication date
CN107296616A (en) 2017-10-27

Similar Documents

Publication Publication Date Title
WO2018214297A1 (en) Portable device and method for non-invasive blood glucose detection
WO2018214298A1 (en) Non-invasive blood glucose detection system and method
CN105877723B (en) Noninvasive continuous blood pressure measurement device
WO2018107915A1 (en) General noninvasive blood glucose prediction method based on timing analysis
EP4225136A1 (en) Personal healthcare device
WO2017024457A1 (en) Blood-pressure continuous-measurement device, measurement model establishment method, and system
CN101467884B (en) Non-invasive method and device for rapidly detecting blood sugar
CN105193423A (en) Non-invasive blood glucose detection method, device and system
CN102028457B (en) Pulse rate measuring method and ring type pulse rate measuring meter
CN101822863A (en) Emotion regulating device and method thereof
US20120108928A1 (en) System and Method for Measurement of Vital Signs of a Human
CN104257368A (en) Device for monitoring sleep and screening obstructive sleep apnea syndrome
EA034599B1 (en) Device for non-invasive measurement of blood sugar level and method for measuring blood sugar level using this device
CN110084085B (en) RPPG high-precision heart rate detection method based on forming signal
CN204666826U (en) The continuous safety check imaging device of a kind of Terahertz
CN115137319A (en) Skin microvascular endothelial function detection equipment and detection method thereof
CN113069091A (en) Pulse condition classification device and method for PPG (photoplethysmography) signals
CN105054943A (en) Oxyhemoglobin saturation detection terminal bringing convenience to monitoring
CN204654954U (en) A kind of Terahertz continuous blood sugar measuring apparatus
CN110575182A (en) Method and device for detecting blood sugar
CN108261202B (en) System for measuring blood sugar and using method thereof
WO2018214299A1 (en) Non-invasive blood glucose data collection apparatus
CN205658894U (en) Infrared sphygmometer based on singlechip
CN210541525U (en) Healthy fingerprint lock
TW201740878A (en) Physiological detection method and device thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17911206

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 04.05.2020)

122 Ep: pct application non-entry in european phase

Ref document number: 17911206

Country of ref document: EP

Kind code of ref document: A1